Zelira Therapeutics Ltd (ZLD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -75 | N/A | -236 | -325 |
| Purchase Of Investment | N/A | -500 | N/A | N/A | N/A |
| Other Investing Activity | -26 | -100 | 0 | 0 | 0 |
| Investing Cash Flow | $-29 | $-675 | $0 | $-236 | $-325 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,350 | N/A | 11,117 | 2,800 |
| Debt Repayment | -900 | N/A | N/A | -8,216 | -2 |
| Common Stock Issued | N/A | 2,333 | 3,305 | 10,768 | 4,218 |
| Common Stock Repurchased | N/A | N/A | N/A | -377 | -157 |
| Other Financing Activity | 0 | 0 | -229 | 21 | 1,056 |
| Financing Cash Flow | $-900 | $3,683 | $3,076 | $13,313 | $7,915 |
| Exchange Rate Effect | -253 | 177 | N/A | N/A | N/A |
| Beginning Cash Position | 2,708 | 1,094 | 229 | 1,962 | 1,460 |
| End Cash Position | 343 | 2,708 | 1,094 | 229 | 1,962 |
| Net Cash Flow | $-2,112 | $1,437 | $865 | $-1,733 | $502 |
| Free Cash Flow | |||||
| Capital Expenditure | -132 | -75 | N/A | -236 | -325 |
| Free Cash Flow | -132 | -75 | 0 | -236 | -325 |